Management of aggressive lymphoma in very elderly patients.

about

Management of aggressive lymphoma in very elderly patients.

Item

http://www.wikidata.org/entity/Q55299219

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Management of aggressive lymphoma in very elderly patients.

@en

Management of aggressive lymphoma in very elderly patients.

@nl

type

Item

label

Management of aggressive lymphoma in very elderly patients.

@en

Management of aggressive lymphoma in very elderly patients.

@nl

prefLabel

Management of aggressive lymphoma in very elderly patients.

@en

Management of aggressive lymphoma in very elderly patients.

@nl

P1476

Management of aggressive lymphoma in very elderly patients.

@en

P2093

Catherine Thieblemont

http://www.w3.org/2001/XMLSchema#string

Sophie Bernard

http://www.w3.org/2001/XMLSchema#string

Thierry Molina

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.

Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma.

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse la

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.

How I treat elderly patients with diffuse large B-cell lymphoma.

The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial.

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome.

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.

P304

49-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/HON.2413

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28591412

http://www.w3.org/2001/XMLSchema#string

P921

lymphoma

P932

5873382

http://www.w3.org/2001/XMLSchema#string